Late Tuesday, Vertex Pharmaceuticals gave the latest sales figures for its newest drug to treat cystic fibrosis, called Orkambi, as well as a timeline for approval of the drug it hopes will replace it in a couple years. Shares of Boston-based Vertex (Nasdaq: VRTX) were trading about flat on Thursday m..."> Late Tuesday, Vertex Pharmaceuticals gave the latest sales figures for its newest drug to treat cystic fibrosis, called Orkambi, as well as a timeline for approval of the drug it hopes will replace it in a couple years. Shares of Boston-based Vertex (Nasdaq: VRTX) were trading about flat on Thursday m..." /> Late Tuesday, Vertex Pharmaceuticals gave the latest sales figures for its newest drug to treat cystic fibrosis, called Orkambi, as well as a timeline for approval of the drug it hopes will replace it in a couple years. Shares of Boston-based Vertex (Nasdaq: VRTX) were trading about flat on Thursday m..." />